Overview:
The Inflation Reduction Act and the resulting Medicare Part D price negotiations are shaping up to be the most far reaching of any event impacting pharma manufacturing in recent history.
Although the first set of negotiated prices for selected drugs will not take effect until January 1, 2026, the immediate impact has been fast and furious - a total of nine lawsuits have been filed by pharmaceutical companies, advocacy groups and the US Chamber of Commerce. Industry media is ablaze with discussions on how price negotiations will impact the pricing of non-selected same-class drugs and biosimilars as well as future drug development in general.
Key discussion topics:
Now that the first-round negotiated prices for selected drugs will be made public on September 1, 2024 and companies prepare themselves for the second round of selections, this timely webinar will provide an update on:
- To-date information on the legal actions, existing price negotiations, and market reactions
- Drugs likely to be selected for the second round and their same-class competitors who will be impacted
- A discussion on how manufacturers should prepare for the overall impact to the industry
Presenters:
Mark McCoy, RPh, MBA
Mark McCoy, RPh, MBA is Director, Client Engagement Pricing Market Access and Reimbursement since 2022. His managed market and brand strategy experience includes work at Invenivhealth, Palio+Ignite, Syneos, GSK and Schering Plough. He earned his BS and MBA from Northeastern University.
Amith Shetty, Pharm.D, RPh
Amith Shetty, Pharm.D, RPh has been a Senior Clinical & Market Access Specialist with ICON since 2022. He holds over 10 years of experience in healthcare, including roles as a community pharmacist, and a clinical preceptor at Thomas Jefferson University. He earned his Doctor of Pharmacy degree from Thomas Jefferson University.
Dr. Xin Zhao
Dr. Xin Zhao is Principal, Global Market Access for ICON. She holds more than 15 years of experience in life sciences focused on drug commercialisation, market access and pricing strategies. She previously worked at GSK, Norstrella, and Citeline. She earned her doctorate from Cardiff University/Prifysgol Caerdydd.
Audience:
This webinar will benefit pharmaceutical and biotech professionals in the following areas:
- Market Access
- Marketing
- Managed Markets
- Market Research
- Real World Evidence
- Regulatory Affairs
- Channel Marketing
- Clinical
- Competitive Intelligence
- Government Affairs
- Health Economics and Outcomes Research